Exelixis, Inc. (EXEL)

TMFBreakerCharly (33.52) Submitted: 5/17/06 5:29 PM : Start Price: $9.37 EXEL Score: -44.48

This small biotech company is the real deal. I think of it as the 2nd coming of Genentech. It has an incredibly deep pipeline of cancer drugs. The deepest oncology pipeline of any biotech for that matter. Even better is that these are high quality co...

Report this Post Replies: 3 | Reply | Permalink

NetscribeBiotech (66.48) Submitted: 1/08/07 2:19 AM : Start Price: $9.48 EXEL Score: -34.34

‘Exelixis all set to excel in 2007’. It is a biotechnology company, which engages in the discovery and development of therapies for the treatment of cancer, renal disease, and various metabolic and cardiovascular disorders.

The company is in the gr...

Report this Post Replies: 1 | Reply | Permalink

Spetty77 (< 20) Submitted: 8/18/06 9:50 PM : Start Price: $8.40 EXEL Score: -34.09

Their drug pipeline is the deepest in the biotech industry, and the compounds they have focus on various types of cancer. They have multiple compounds in various stages of Phase II testing, and so far the results have all been positive. They will be ...

Report this Post Replies: 0 | Reply | Permalink

HologramMan (86.14) Submitted: 3/15/07 9:46 PM : Start Price: $9.54 EXEL Score: 35.84

This company is touted to be the next Genentech but I'm not buying it. Exel has a lot of eggs and no chickens. If one of these eggs hatches, then it's great for everyone, but at this early in the game it's really impossible for anyone to know what's ...

Report this Post Replies: 2 | Reply | Permalink

jcm56 (71.98) Submitted: 9/22/06 9:04 PM : Start Price: $8.89 EXEL Score: -37.23

Small company with lots of drugs in various clinical phases. As a physician, I feel good about the future prospects of targeted cancer therapies--the improved side-effect profile and molecular specificity just make a whole lot of sense. That being ...

Report this Post Replies: 0 | Reply | Permalink

ResearchLover (98.29) Submitted: 3/12/08 12:11 PM : Start Price: $5.29 EXEL Score: 12.73

I am a molecular biologist and have been at presentations for mid/late stage compounds, such as PPAR ligands, that EXEL is developing. They have the expertise to develop successful compounds. And they are at a bargain basement price now. If you ne...

Report this Post Replies: 0 | Reply | Permalink

chaos1978 (53.82) Submitted: 6/21/07 4:50 AM : Start Price: $11.42 EXEL Score: -38.59

I like the way Exelixis searches for therapeutic compounds. I had an interview with them a couple years ago, but went down another healthcare oriented avenue (would have been one heck of a commute to work at their greenhouses). The potential for bi...

Report this Post Replies: 1 | Reply | Permalink

canadianbikeguy (< 20) Submitted: 6/01/06 1:50 AM : Start Price: $10.91 EXEL Score: -53.78

biotech will have it's day again in the next two years.......and this little company has a strong pipeline giving it a high probability of some kind of success in the short, medium and long terms.

Report this Post Replies: 0 | Reply | Permalink

ari21 (91.24) Submitted: 9/24/06 3:22 PM : Start Price: $8.99 EXEL Score: -37.66

this is a risky stock. Biotec company. Their drug pipeline, and the quality of the partnerships increases their chances to be a winning company in that risky sector.Only invest a small percent of your portfolio. Even with the positive resullts they g...

Report this Post Replies: 0 | Reply | Permalink

iksnamyzs (23.37) Submitted: 5/30/06 11:34 PM : Start Price: $10.36 EXEL Score: -51.37

This pick is based soley on Rulebreaker charly's pcik in the rulebreakers newsletter. He stated it's a good buy in price and expects the stock to rise based on the drugs it has in testing to be ok'd by the fed for cancer treatment.

Report this Post Replies: 0 | Reply | Permalink